122 related articles for article (PubMed ID: 37551483)
1. [Risk Factors of Multiple Myeloma Complicated with Venous Thromboembolism].
Zhao BN; Dong CX; Kang JM; Ge XY; Zhang JH; Wang MF; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1100-1107. PubMed ID: 37551483
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
[TBL] [Abstract][Full Text] [Related]
3. Relevant detection indicator of prethrombotic state in patients with primary hypertension.
Luo J; Yang T; Ding L; Xiong JH; Ying T; Xu F
World J Clin Cases; 2023 Aug; 11(24):5678-5691. PubMed ID: 37727711
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
[TBL] [Abstract][Full Text] [Related]
6. Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil.
da Costa IHF; de Pádua CAM; de Miranda Drummond PL; Silveira LP; Malta JS; Dos Santos RMM; Reis AMM
Support Care Cancer; 2023 Dec; 32(1):35. PubMed ID: 38103099
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease.
Habe K; Wada H; Mizutani K; Matsushima Y; Kondo M; Yamanaka K
Clin Rheumatol; 2021 Nov; 40(11):4675-4683. PubMed ID: 34136970
[TBL] [Abstract][Full Text] [Related]
8. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study.
Zhang F; Liu L; Sha Y
Cancer Control; 2022; 29():10732748221127826. PubMed ID: 36223407
[TBL] [Abstract][Full Text] [Related]
10. [Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
Cui S; Li H; Tian B; Song C; Hu B
Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):753-760. PubMed ID: 30309426
[TBL] [Abstract][Full Text] [Related]
11. Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?
Wannamethee SG; Papacosta O; Lennon L; Whincup PH; Rumley A; Lowe GDO
Br J Haematol; 2022 Aug; 198(3):587-594. PubMed ID: 35655415
[TBL] [Abstract][Full Text] [Related]
12. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.
Kuk A; Magnowska M; Suchy W; Swierczynska J; Zaborowski MP; Gaca M; Nowak-Markwitz E
Target Oncol; 2017 Aug; 12(4):495-503. PubMed ID: 28580507
[TBL] [Abstract][Full Text] [Related]
15. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
[No Abstract] [Full Text] [Related]
16. [The Influence of CONUT Score on the Prognosis of Patients with Multiple Myeloma].
Li YQ; Wang Y; Song Y; Han Y; Li JJ; Yue LL; Zeng PY; Wu CY; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):781-786. PubMed ID: 34105472
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of patients with venous thromboembolism: 177 case analysis in 10 years].
Gong B; Xu Q; Pang Y; Hu J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):453-457. PubMed ID: 31109420
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort.
da Costa IHF; de Pádua CAM; de Miranda Drummond PL; Silveira LP; Malta JS; Dos Santos RMM; Reis AMM
J Thromb Thrombolysis; 2023 Jul; 56(1):147-155. PubMed ID: 37133703
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of high-risk factors and clinical characteristics of sepsis-related liver injury].
Lin H; Liang Q; Cai Q; Huang M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):186-191. PubMed ID: 33729138
[TBL] [Abstract][Full Text] [Related]
20. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
